HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paul R Barber Selected Research

Paul R Barber Research Topics

Disease

23Neoplasms (Cancer)
04/2024 - 07/2003
6Breast Neoplasms (Breast Cancer)
10/2020 - 05/2011
3Colorectal Neoplasms (Colorectal Cancer)
01/2023 - 01/2017
2Carcinoma (Carcinomatosis)
03/2015 - 02/2004
2Fibrosarcoma
12/2013 - 04/2008
1Ovarian Neoplasms (Ovarian Cancer)
04/2024
1Rupture
04/2024
1Squamous Cell Carcinoma of Head and Neck
12/2022
1Head and Neck Neoplasms (Head and Neck Cancer)
12/2022
1Prostatic Neoplasms (Prostate Cancer)
01/2022
1Carcinogenesis
10/2020
1Lung Neoplasms (Lung Cancer)
01/2020
1Colonic Neoplasms (Colon Cancer)
01/2017
1Lymphatic Metastasis
01/2017
1Laryngeal Neoplasms (Laryngeal Cancer)
12/2015
1Neoplasm Metastasis (Metastasis)
12/2014
1Necrosis
12/2013
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2012
1Adenocarcinoma
08/2012
1Hypoxia (Hypoxemia)
08/2012
1Sarcoma (Soft Tissue Sarcoma)
01/2008
1Rectal Neoplasms (Rectal Cancer)
12/2005

Drug/Important Bio-Agent (IBA)

9Proteins (Proteins, Gene)FDA Link
01/2022 - 02/2004
3Biomarkers (Surrogate Marker)IBA
12/2022 - 08/2012
3Cetuximab (Erbitux)FDA Link
12/2022 - 01/2017
3Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2022 - 12/2013
2EnzymesIBA
10/2020 - 11/2011
2Coloring Agents (Dyes)IBA
07/2017 - 12/2005
2ParaffinIBA
08/2016 - 09/2009
2Trastuzumab (Herceptin)FDA Link
08/2016 - 05/2011
2Formaldehyde (Formol)FDA Link
08/2016 - 09/2009
2TubulinIBA
12/2013 - 04/2008
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2013 - 04/2008
2Protein Isoforms (Isoforms)IBA
12/2013 - 04/2008
2Contrast MediaIBA
08/2012 - 01/2008
2fluorescein isothiocyanate dextranIBA
04/2008 - 01/2008
1tetraphenylporphineIBA
04/2024
1PorphyrinsIBA
04/2024
1CollagenIBA
04/2024
11-phenyl-3,3-dimethyltriazene (PDT)IBA
04/2024
1AZD 8931IBA
01/2023
1PlatinumIBA
12/2022
1avelumabIBA
12/2022
1metabotropic glutamate receptor type 1IBA
01/2022
1Androgen Receptors (Androgen Receptor)IBA
01/2022
1Succinic Acid (Succinate)IBA
10/2020
1Succinate Dehydrogenase (Fumarate Reductase)IBA
10/2020
1Transcription Factors (Transcription Factor)IBA
10/2020
1CytokinesIBA
10/2020
1STAT1 Transcription FactorIBA
10/2020
1trastuzumab deruxtecanIBA
01/2020
1Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2020
1Immunoconjugates (Immunoconjugate)IBA
01/2020
1Cytotoxins (Cytolysins)IBA
01/2020
1Ado-Trastuzumab EmtansineIBA
01/2020
1Small Interfering RNA (siRNA)IBA
01/2018
1Endosomal Sorting Complexes Required for TransportIBA
01/2018
1Molecular Probes (Molecular Probe)IBA
07/2017
1ChemokinesIBA
01/2017
1pertuzumabIBA
08/2016
1ErbB Receptors (EGF Receptor)IBA
03/2015
1ezrinIBA
12/2014
1Protein Kinases (Protein Kinase)IBA
12/2014
1Actin Depolymerizing Factors (Cofilins)IBA
12/2014
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
12/2013
1fosbretabulin (combretastatin A4)IBA
12/2013
1OxindolesIBA
12/2013
1Semaxinib (SU5416)IBA
12/2013
1pimonidazoleIBA
08/2012
1Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
08/2012
1AntibodiesIBA
09/2011
1L 778,123IBA
05/2011
1Tumor Biomarkers (Tumor Markers)IBA
04/2011
1Dextrans (Dextran)FDA Link
01/2008
1isothiocyanic acidIBA
01/2008
1Fluorescein-5-isothiocyanate (FITC)IBA
01/2008
1combretastatinIBA
01/2008
1Fluorescein (Funduscein)FDA LinkGeneric
01/2008
1Thymidylate SynthaseIBA
12/2005
1Cytochrome P-450 CYP1B1IBA
02/2004

Therapy/Procedure

15Therapeutics
12/2022 - 07/2003
4Drug Therapy (Chemotherapy)
01/2023 - 08/2016
1Laryngectomy
12/2015